Clinical and imaging manifestations of metastases from rare sites

Because various primary cancers may metastasize to rare sites, metastatic tumors have a wide variety of imaging presentations. Their imaging appearance primarily depends on features related to the primary tumor, such as the degree of tumor differentiation, histopathologic category, tumor markers, and intratumor alterations. In certain clinical situations, imaging features and clinical history may help provide a more accurate diagnosis. Metastatic tumors can involve almost any organ, but the recognition of rare sites of metastasis is insufficient. Because clinical manifestations are heterogeneous and imaging manifestations are atypical, these metastatic tumors can easily be misdiagnosed or missed. Radiology plays an important role in the diagnosis and follow-up of patients with metastatic tumors. Computed tomography (CT) and magnetic resonance imaging (MRI) are the primary imaging modalities used to evaluate metastatic tumors and to differentiate metastatic tumors from other diseases (particularly primary organ tumors or inflammatory conditions). In this study, the principal clinical, histopathological, and imaging characteristics of metastases to uncommon sites were synthesized, with the dual aim of refining organ-specific differential diagnoses and providing a comprehensive overview of the variable manifestations of this rare condition. The marked morphologic heterogeneity of these metastases constitutes a formidable diagnostic challenge. The interpretation of various imaging findings plays a crucial role in the diagnosis and follow-up of patients with metastatic tumors at rare sites and may be critical to informing treatment decisions.